Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00417937
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2007-01-02
Brief Title:
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
A Multicenter Double-Blind Clinical Trial to Assess the Efficacy and Tolerability of Topical Azelaic Acid 15 Gel Once Daily Compared to Topical Azelaic Acid 15 gelTwice Daily in Subjects With Papulopustular Rosacea
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the efficacy and tolerability of azelaic acid 15 gel applied once daily versus twice daily in the treatment of patients with papulopustular rosacea
Detailed Description:
To test the efficacy and safety of once vs twice daily application of azelaic acid 15 gel on papulopustular rosacea
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1401460 | OTHER | Company internal | None |